Sale by Michael Wiley of 2357 shares of Guardant Health

GH Stock  USD 30.44  0.93  2.96%   
Under 81 percent of Guardant Health's traders are selling. The analysis of overall sentiment of trading Guardant Health stock suggests that a large number of investors are terrified at this time. Guardant Health's investing sentiment shows overall attitude of investors towards Guardant Health.
  
Filed transaction by Guardant Health Inc officer. General open market or private sale of non-derivative or derivative security

Read at macroaxis.com
Guardant insider trading alert for sale of common stock by Michael Wiley, Chief Legal Officer, on 24th of May 2023. This event was filed by Guardant Health Inc with SEC on 2019-08-16. Statement of changes in beneficial ownership - SEC Form 4

Guardant Health Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Guardant Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Guardant Health Fundamental Analysis

We analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Liabilities

Current Liabilities Comparative Analysis

Guardant Health is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Guardant Health Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guardant Health stock to make a market-neutral strategy. Peer analysis of Guardant Health could also be used in its relative valuation, which is a method of valuing Guardant Health by comparing valuation metrics with similar companies.

Peers

Guardant Health Related Equities

PSNLPersonalis   2.79   
0%
100.0%
NTRANatera   0.39   
0%
13.0%
CDNACaredx   0.09   
0%
3.0%
DHRDanaher   0.04   
0%
1.0%
ILMNIllumina   0.18   
6.0%
0%
AAgilent Technologies   0.21   
7.0%
0%
CRLCharles River   0.26   
9.0%
0%
TMOThermo Fisher   0.34   
12.0%
0%
MYGNMyriad Genetics   0.59   
21.0%
0%
TWSTTwist Bioscience   2.15   
77.0%
0%
CSTLCastle Biosciences   2.24   
80.0%
0%

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios